KIM PETER S 4
4 · Entrada Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
KIM PETER S
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-03$6.06/sh+11,918$72,223→ 104,330 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-03−11,918→ 0 totalExercise: $6.06Exp: 2032-06-02→ Common Stock (11,918 underlying)
Footnotes (1)
- [F1]The shares subject to this option fully vested on June 2, 2023.